Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure

Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure

US Patent 11235031 · Granted Feb 1, 2022

Estimated economic value: $419,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of reducing extravasation of inflammatory cells2021
Methods for detecting cardiac damage2021
Method for achieving desired glial growth factor 2 plasma levels2020
Compositions and methods for treatment during non-acute periods following CNS ne2020
Compositions and methods for treatment during non-acute periods following CNS ne2020
Compositions and methods of using chondroitinase ABCI mutants2019
Compositions and methods of using chondroitinase ABCI mutants2019
Methods for detecting cardiac damage2019
Compositions and methods of using chondroitinase ABCI mutants2018
Compositions and methods of using chondroitinase ABCI mutants2018
Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or pro2018
Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or pro2018